Next 10 |
2024-05-17 16:32:34 ET More on Jaguar Health Jaguar stock rallies 54% on licensing deal for chemo support drug Jaguar Health shareholders approve reverse stock split Seeking Alpha’s Quant Rating on Jaguar Health Read the full article on Seeking Alpha...
Reverse split approved at April 2024 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split-adjusted basis on May 23, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today anno...
2024-05-14 13:06:07 ET Jaguar Health, Inc. (JAGX) Q1 2024 Earnings Conference Call May 14, 2024, 08:30 AM ET Company Participants Lisa Conte - Founder, President and CEO Carol Lizak - CFO Conference Call Participants Presentation Operator ...
2024-05-14 09:14:57 ET More on Jaguar Health Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript Jaguar stock rallies 54% on licensing deal for chemo support drug Jaguar Health shareholders approve reverse stock split Seeking Alpha’s Quant Rati...
The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net Q1 2023 revenue of $2.0 million and increased approximately 4% versus net Q4 2023 revenue of $2.3 million Top line results expected to be immin...
Click here to register for May 14 investor webcast Company plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 13, 2024 / Jaguar Health, Inc. ( NASDAQ:JAGX ) today issued a reminder that th...
2024-05-13 12:09:55 ET More on Jaguar Health Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript Jaguar stock rallies 54% on licensing deal for chemo support drug Jaguar Health shareholders approve reverse stock split Seeking Alpha’s Quant Rati...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 20.3% to $0.0699 on volume of 164,902,840 shares Safe and Green Development Corporation (SGD) rose 36.7% to $0.8477 on volume of 100,466,382 shares PROSHARES TRUST (SQQQ) fell 0.6% to $1...
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and SBS SAN FRANCISCO, CA / ACCESSWIRE / May 9, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Jaguar fam...
Click here to register for May 14 investor webcast Company plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 8, 2024 / Jaguar Health, Inc. ( NASDAQ:JAGX ) today announced that the company...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
5.06%Change Percent:
Jaguar Health Inc. Company Name:
JAGX Stock Symbol:
NASDAQ Market:
Jaguar Health Inc. Website:
Reverse split approved at April 2024 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split-adjusted basis on May 23, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today anno...
The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net Q1 2023 revenue of $2.0 million and increased approximately 4% versus net Q4 2023 revenue of $2.3 million Top line results expected to be immin...
Click here to register for May 14 investor webcast Company plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 13, 2024 / Jaguar Health, Inc. ( NASDAQ:JAGX ) today issued a reminder that th...